Novak & Powell Financial Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Novak & Powell Financial Services’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$375K	Hold	1,512	–	–	0.18%	117
2026 Q1	$304K	Hold	1,512	–	–	0.16%	123
2025 Q4	$312K	Hold	1,512	–	–	0.16%	115
2025 Q3	$271K	Hold	1,512	–	–	0.14%	131
2025 Q2	$244K	Hold	1,512	–	–	0.17%	125
2025 Q1	$257K	Hold	1,512	–	–	0.16%	124
2024 Q4	$251K	Hold	1,512	–	–	0.15%	124
2024 Q3	$260K	Hold	1,512	–	–	0.15%	122
2024 Q2	$233K	Hold	1,512	–	–	0.14%	127
2024 Q1	$233K	Sell	1,512 -198	-12%	-$30.2K	0.17%	119
2023 Q4	$270K	Buy	+1,710	New	+$246K	0.18%	110

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Novak & Powell Financial Services's FBT Position: Q2 2026 in Review

Novak & Powell Financial Services held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 1,512 shares worth $375K. The position accounts for 0.18% of the portfolio, ranked #117.

Novak & Powell Financial Services first reported a position in FBT in Q4 2023 and has held it in 11 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Novak & Powell Financial Services held 1,512 shares of First Trust NYSE Arca Biotechnology Index Fund worth $375K as of Q2 2026.
Novak & Powell Financial Services left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.18% of Novak & Powell Financial Services's portfolio in Q2 2026, its #117 holding.
Novak & Powell Financial Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 11 quarters since.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Novak & Powell Financial Services's 13F filing for Q2 2026, filed 11 Aug 2026.